Enhancement in selective mitochondrial association by direct modification of a mitochondrial targeting signal peptide on a liposomal based nanocarrier

Mitochondrion

Volumn 13, Issue 5, 2013, Pages 526-532

  Yamada, Yuma ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Membrane fusion; MITO Porter; Mitochondria; Mitochondrial drug delivery; Mitochondrial targeting signal peptide (MTS); Nanotechnology

Indexed keywords

CHOLESTEROL; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; GREEN FLUORESCENT PROTEIN; LIPOSOME; NANOCARRIER; PHOSPHATIDYLCHOLINE; RHODAMINE; SIGNAL PEPTIDE;

ARTICLE; CELL FREE SYSTEM; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; MEMBRANE FUSION; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL TARGETING SIGNAL; NONHUMAN; PRIORITY JOURNAL;

MEMBRANE FUSION; MITO-PORTER; MITOCHONDRIA; MITOCHONDRIAL DRUG DELIVERY; MITOCHONDRIAL TARGETING SIGNAL PEPTIDE (MTS); NANOTECHNOLOGY;

DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MITOCHONDRIA; PROTEIN SORTING SIGNALS;

EID: 84882827086     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2012.09.001     Document Type: Article

References (36)

1. Armstrong J.S. Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br. J. Pharmacol. 2007, 151:1154-1165.
2. Asayama S., Kawamura E., Nagaoka S., Kawakami H. Design of manganese porphyrin modified with mitochondrial signal peptide for a new antioxidant. Mol. Pharm. 2006, 3:468-470.
3. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006, 125:1241-1252.
4. D'Souza G.G.M., Cheng S.M., Boddapati S.V., Horobin R.W., Weissig V. Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel. J. Drug Target. 2008, 16:578-585.
5. Du H., Yan S.S.D. Mitochondrial medicine for neurodegenerative diseases. Int. J. Biochem. Cell Biol. 2010, 42:560-572.
6. Endo T., Nakayama Y., Nakai M. Avidin fusion protein as a tool to generate a stable translocation intermediate spanning the mitochondrial membranes. J. Biochem. (Tokyo) 1995, 118:753-759.
7. Esaki M., Kanamori T., Nishikawa S., Endo T. Two distinct mechanisms drive protein translocation across the mitochondrial outer membrane in the late step of the cytochrome b(2) import pathway. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11770-11775.
8. Flierl A., Jackson C., Cottrell B., Murdock D., Seibel P., Wallace D.C. Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid. Mol. Ther. 2003, 7:550-557.
9. Fulda S., Galluzzi L., Kroemer G. Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov. 2010, 9:447-464.
10. Giorgi C., Agnoletto C., Bononi A., Bonora M., De Marchi E., Marchi S., Missiroli S., Patergnani S., Poletti F., Rimessi A., Suski J.M., Wieckowski M.R., Pinton P. Mitochondrial calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion 2012, 12:77-85.
11. Gogvadze V., Orrenius S., Zhivotovsky B. Mitochondria as targets for cancer chemotherapy. Semin. Cancer Biol. 2009, 19:57-66.
12. Gruhler A., Ono H., Guiard B., Neupert W., Stuart R.A. A novel intermediate on the import pathway of cytochrome b2 into mitochondria: evidence for conservative sorting. EMBO J. 1995, 14:1349-1359.
13. Henning W.D., Upton C., McFadden G., Majumdar R., Bridger W.A. Cloning and sequencing of the cytoplasmic precursor to the alpha subunit of rat liver mitochondrial succinyl-CoA synthetase. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:1432-1436.
14. James A.M., Sharpley M.S., Manas A.R., Frerman F.E., Hirst J., Smith R.A., Murphy M.P. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J. Biol. Chem. 2007, 282:14708-14718.
15. Juliano R.L., Alam R., Dixit V., Kang H.M. Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009, 1:324-335.
16. Maier O., Oberle V., Hoekstra D. Fluorescent lipid probes: some properties and applications (a review). Chem. Phys. Lipids 2002, 116:3-18.
17. Miyata K., Nishiyama N., Kataoka K. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. Chem. Soc. Rev. 2012, 41:2562-2574.
18. Mohanty C., Das M., Kanwar J.R., Sahoo S.K. Receptor mediated tumor targeting: an emerging approach for cancer therapy. Curr. Drug Dev. 2011, 8:45-58.
19. Mukhopadhyay A., Weiner H. Delivery of drugs and macromolecules to mitochondria. Adv. Drug Deliv. Rev. 2007, 59:729-738.
20. Pack D.W., Hoffman A.S., Pun S., Stayton P.S. Design and development of polymers for gene delivery. Nat. Rev. Drug Discov. 2005, 4:581-593.
21. Reeve A.K., Krishnan K.J., Turnbull D. Mitochondrial DNA mutations in disease, aging, and neurodegeneration. Ann. N. Y. Acad. Sci. 2008, 1147:21-29.
22. Schapira A.H. Mitochondrial disease. Lancet 2006, 368:70-82.
23. Schatz G. The protein import system of mitochondria. J. Biol. Chem. 1996, 271:31763-31766.
24. Struck D.K., Hoekstra D., Pagano R.E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 1981, 20:4093-4099.
25. Szewczyk A., Wojtczak L. Mitochondria as a pharmacological target. Pharmacol. Rev. 2002, 54:101-127.
26. Wallace D.C. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 2005, 354:169-180.
27. Wang T., Upponi J.R., Torchilin V.P. Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies. Int. J. Pharm. 2012, 427:3-20.
28. Wipf P., Xiao J., Jiang J., Belikova N.A., Tyurin V.A., Fink M.P., Kagan V.E. Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates. J. Am. Chem. Soc. 2005, 127:12460-12461.
29. Yamada Y., Akita H., Harashima H. Multifunctional envelope-type nano device (MEND) for organelle targeting via a stepwise membrane fusion process. Methods Enzymol. 2012, 509:301-326.
30. Yamada Y., Akita H., Kamiya H., Kogure K., Yamamoto T., Shinohara Y., Yamashita K., Kobayashi H., Kikuchi H., Harashima H. MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim. Biophys. Acta 2008, 1778:423-432.
31. Yamada Y., Akita H., Kogure K., Kamiya H., Harashima H. Mitochondrial drug delivery and mitochondrial disease therapy - an approach to liposome-based delivery targeted to mitochondria. Mitochondrion 2007, 7:63-71.
32. Yamada Y., Furukawa R., Yasuzaki Y., Harashima H. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery. Mol. Ther. 2011, 19:1449-1456.
33. Yamada Y., Harashima H. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv. Drug Deliv. Rev. 2008, 60:1439-1462.
34. Yamada Y., Harashima H. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter. Biomaterials 2012, 33:1589-1595.
35. Yasuzaki Y., Yamada Y., Harashima H. Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes. Biochem. Biophys. Res. Commun. 2010, 397:181-186.
36. Zhang E., Zhang C., Su Y., Cheng T., Shi C. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy. Drug Discov. Today 2011, 16:140-146.